Sylvia Snauwaert

Brugge, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Optimizing Anemia Diagnosis: Clinical Evaluation of an Automated, Diagnostic Anemia Protocol.

Optimizing Anemia Diagnosis: Clinical Evaluation of an Automated, Diagnostic Anemia Protocol.

Journal: International journal of laboratory hematology
Published: April 17, 2026

First-line treatment with epcoritamab in combination with bendamustine plus rituximab induces sustained remissions beyond 3 years in patients with follicular lymphoma.

First-line treatment with epcoritamab in combination with bendamustine plus rituximab induces sustained remissions beyond 3 years in patients with follicular lymphoma.

Journal: HemaSphere
Published: March 25, 2026

Fixed-duration epcoritamab plus R-CHOP in newly diagnosed LBCL with IPI score 3-5: results from the EPCORE NHL-2 trial.

Fixed-duration epcoritamab plus R-CHOP in newly diagnosed LBCL with IPI score 3-5: results from the EPCORE NHL-2 trial.

Journal: Blood
Published: March 25, 2026

Prospective surveillance of Candida auris and assessment of diagnostic approaches in a Belgian hospital.

Prospective surveillance of Candida auris and assessment of diagnostic approaches in a Belgian hospital.

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Published: May 26, 2025

Assessing the Persistence and Relevance of Small T-LGL Clones via TRBC1 in a Flowcytometric Lymphoid Screening Tube.

Assessing the Persistence and Relevance of Small T-LGL Clones via TRBC1 in a Flowcytometric Lymphoid Screening Tube.

Journal: International journal of laboratory hematology
Published: April 10, 2025

Risk Factors and Outcome of HHV-6 Infections After Allogeneic Hematopoietic Cell Transplantation.

Risk Factors and Outcome of HHV-6 Infections After Allogeneic Hematopoietic Cell Transplantation.

Journal: Open forum infectious diseases
Published: April 04, 2025

Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study.

Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study.

Journal: Blood advances
Published: January 02, 2025

Atezolizumab consolidation in patients with high-risk diffuse large B-cell lymphoma in complete remission after R-CHOP.

Atezolizumab consolidation in patients with high-risk diffuse large B-cell lymphoma in complete remission after R-CHOP.

Journal: Blood advances
Published: November 01, 2024

Real-world insights on the management of immune-mediated thrombotic thrombocytopenic purpura with caplacizumab.

Real-world insights on the management of immune-mediated thrombotic thrombocytopenic purpura with caplacizumab.

Journal: Blood vessels, thrombosis & hemostasis
Published: February 07, 2024

Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study.

Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study.

Journal: The Lancet. Haematology
Published: January 23, 2024

Epidemiological Characteristics and Outcome of Viral Respiratory Tract Infections in the First Year After Allogeneic Hematopoietic Cell Transplantation.

Epidemiological Characteristics and Outcome of Viral Respiratory Tract Infections in the First Year After Allogeneic Hematopoietic Cell Transplantation.

Journal: The Journal of infectious diseases
Published: November 10, 2023

Alternative genetic alterations of MYC, BCL2, and/or BCL6 in high-grade B-cell lymphoma (HGBL) and diffuse large B-cell lymphoma (DLBCL): Can we identify different prognostic subgroups?

Alternative genetic alterations of MYC, BCL2, and/or BCL6 in high-grade B-cell lymphoma (HGBL) and diffuse large B-cell lymphoma (DLBCL): Can we identify different prognostic subgroups?

Journal: Genes, chromosomes & cancer
Published: July 05, 2023
Showing 1-12 of 29

Last Updated: 09/26/2026